TRETHIA Trademark

Trademark Overview


On Wednesday, August 1, 2012, a trademark application was filed for TRETHIA with the United States Patent and Trademark Office. The USPTO has given the TRETHIA trademark a serial number of 85692717. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, October 7, 2013. This trademark is owned by Agouron Pharmaceuticals, Inc.. The TRETHIA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, genetic immunological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations for use in hematology; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations, smoking cessation preparations, and tissue repair preparations; vaccines for human use
trethia

General Information


Serial Number85692717
Word MarkTRETHIA
Filing DateWednesday, August 1, 2012
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, October 7, 2013
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 8, 2013

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, genetic immunological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations for use in hematology; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations, smoking cessation preparations, and tissue repair preparations; vaccines for human use

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, August 9, 2012
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAgouron Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121

Party NameAgouron Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121

Trademark Events


Event DateEvent Description
Monday, October 7, 2013ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, October 7, 2013ABANDONMENT - NO USE STATEMENT FILED
Tuesday, March 5, 2013NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 8, 2013PUBLISHED FOR OPPOSITION
Wednesday, December 19, 2012NOTICE OF PUBLICATION
Thursday, November 29, 2012APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, November 29, 2012ASSIGNED TO EXAMINER
Thursday, August 9, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, August 4, 2012NEW APPLICATION ENTERED IN TRAM